|
NL130088C
(enExample)
|
1960-03-14 |
|
|
|
|
WO1994006802A1
(fr)
*
|
1992-09-18 |
1994-03-31 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Compose de thienodiazepine et son utilisation medicinale
|
|
GB9420763D0
(en)
|
1994-10-14 |
1994-11-30 |
Glaxo Inc |
Acetamide derivatives
|
|
GB9919776D0
(en)
|
1998-08-31 |
1999-10-27 |
Zeneca Ltd |
Compoujnds
|
|
AU7961300A
(en)
|
1999-10-29 |
2001-05-14 |
Yamanouchi Pharmaceutical Co., Ltd. |
Kainic acid neurocytotoxicity inhibitors
|
|
AU2001262185A1
(en)
|
2000-04-10 |
2001-10-23 |
Novartis Ag |
Substituted (hetero)aryl carboxamide derivatives as microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) secretion
|
|
EP1364659B1
(en)
|
2001-02-08 |
2009-11-11 |
Ono Pharmaceutical Co., Ltd. |
Remedies for urinary diseases comprising lpa receptor controlling agents
|
|
TW200403058A
(en)
|
2002-04-19 |
2004-03-01 |
Bristol Myers Squibb Co |
Heterocyclo inhibitors of potassium channel function
|
|
US7435824B2
(en)
|
2002-04-19 |
2008-10-14 |
Bristol-Myers Squibb Company |
Prodrugs of potassium channel inhibitors
|
|
TW200505902A
(en)
|
2003-03-20 |
2005-02-16 |
Schering Corp |
Cannabinoid receptor ligands
|
|
CN102584813B
(zh)
|
2003-05-14 |
2016-07-06 |
Ngc药物公司 |
化合物及其在调节淀粉样蛋白β中的用途
|
|
SG146624A1
(en)
|
2003-09-11 |
2008-10-30 |
Kemia Inc |
Cytokine inhibitors
|
|
WO2005037269A1
(ja)
|
2003-10-21 |
2005-04-28 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規ピペリジン誘導体
|
|
CA2544981A1
(en)
|
2003-11-12 |
2005-05-26 |
Merck & Co., Inc. |
4-phenyl piperidine sulfonyl glycine transporter inhibitors
|
|
EP1687296A1
(en)
|
2003-11-18 |
2006-08-09 |
Warner-Lambert Company LLC |
Antibacterial aminoquinazolidinedione derivatives
|
|
WO2006091862A2
(en)
|
2005-02-24 |
2006-08-31 |
Kemia, Inc. |
Cytokine inhibitors and their use in therapy
|
|
TWI377198B
(en)
|
2005-08-24 |
2012-11-21 |
Eisai R&D Man Co Ltd |
Novel pyridine derivatives and pyrimidine derivatives (3)
|
|
WO2007058990A2
(en)
|
2005-11-14 |
2007-05-24 |
Kemia, Inc. |
Therapy using cytokine inhibitors
|
|
EP2035005A4
(en)
|
2006-06-09 |
2011-07-06 |
Kemia Inc |
THERAPY BASED ON CYTOKINE INHIBITORS
|
|
JP5164510B2
(ja)
|
2006-10-06 |
2013-03-21 |
日本曹達株式会社 |
含窒素複素環化合物および有害生物防除剤
|
|
WO2008115281A2
(en)
|
2006-10-16 |
2008-09-25 |
Myriad Genetics, Inc. |
Compounds for treating viral infections
|
|
AU2008311971A1
(en)
|
2007-10-18 |
2009-04-23 |
Merck Sharp & Dohme Corp. |
Quinolizidinone M1 receptor positive allosteric modulators
|
|
EP2297153B1
(en)
|
2008-04-21 |
2015-05-27 |
Lexicon Pharmaceuticals, Inc. |
Limk2 inhibitors, compositions comprising them, and methods of their use
|
|
AU2009243756B2
(en)
|
2008-05-05 |
2013-06-27 |
Sanofi-Aventis |
Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
|
|
BRPI0918971A2
(pt)
|
2008-08-26 |
2015-12-01 |
Boehringer Ingelheim Int |
tienopirimidinas para composições farmacêuticas
|
|
JP5708936B2
(ja)
|
2009-09-25 |
2015-04-30 |
アステラス製薬株式会社 |
置換アミド化合物
|
|
ES2682303T3
(es)
|
2010-08-05 |
2018-09-19 |
Zoetis Services Llc |
Derivados de isoxazolina como agentes antiparasitarios
|
|
TW201305178A
(zh)
|
2010-10-29 |
2013-02-01 |
Glenmark Pharmaceuticals Sa |
作為ｍＰＧＥＳ－１抑制物的三環化合物
|
|
CN107721940A
(zh)
|
2010-12-07 |
2018-02-23 |
阿米拉制药公司 |
多环lpa1拮抗剂及其使用
|
|
EP2651930B1
(en)
|
2010-12-16 |
2015-10-28 |
Boehringer Ingelheim International GmbH |
Biarylamide inhibitors of leukotriene production
|
|
PT2683723T
(pt)
|
2011-03-10 |
2016-08-05 |
Zoetis Services Llc |
Derivados espirocíclicos de isoxazolina como agentes antiparasitários
|
|
JP2015506349A
(ja)
|
2011-12-21 |
2015-03-02 |
アルデリックス， インコーポレイテッド |
非全身性ｔｇｒ５アゴニスト
|
|
WO2014079805A1
(en)
|
2012-11-23 |
2014-05-30 |
Boehringer Ingelheim International Gmbh |
Pyrazole compounds for treating hairloss
|
|
TW201444820A
(zh)
*
|
2013-03-13 |
2014-12-01 |
Abbvie Inc |
吡啶ｃｄｋ９激酶抑制劑
|
|
JP2017500287A
(ja)
|
2013-11-06 |
2017-01-05 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
Ｇｓｋ−３阻害剤として有用な置換ピリジン誘導体
|
|
AR108185A1
(es)
|
2016-04-06 |
2018-07-25 |
Abbvie Inc |
Amidas terciarias y método para su uso
|
|
HUE061559T2
(hu)
|
2018-06-07 |
2023-07-28 |
Idorsia Pharmaceuticals Ltd |
Alkoxi-helyettesített piridinil származékok mint LAP1 receptor antagonisták és fibrózis kezelésében való alkalmazásuk
|
|
WO2021110805A1
(en)
|
2019-12-04 |
2021-06-10 |
Idorsia Pharmaceuticals Ltd |
Combination of an azetidine lpa1 receptor antagonist with pirfenidone and/or nintedanib for use in the treatment of fibrotic diseases
|